Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Amirhosein Akhavan Sigari, Seyed Mohammad Piran Daliyeh, Mohammad Reza Maracy, Mehri Salari, Shiva Maleki, View ORCID ProfileNahad Sedaghat
doi: https://doi.org/10.1101/2021.10.17.21265114
Masoud Etemadifar
1Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Amir Parsa Abhari
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
Hosein Nouri
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
Amirhosein Akhavan Sigari
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Seyed Mohammad Piran Daliyeh
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Mohammad Reza Maracy
4Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
Mehri Salari
5Department of Neurology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Shiva Maleki
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Nahad Sedaghat
2Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
3Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
Data Availability
All anonymized data produced in the present study are available upon reasonable request from any qualified investigator to the authors.
Posted October 21, 2021.
Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Amirhosein Akhavan Sigari, Seyed Mohammad Piran Daliyeh, Mohammad Reza Maracy, Mehri Salari, Shiva Maleki, Nahad Sedaghat
medRxiv 2021.10.17.21265114; doi: https://doi.org/10.1101/2021.10.17.21265114
Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Amirhosein Akhavan Sigari, Seyed Mohammad Piran Daliyeh, Mohammad Reza Maracy, Mehri Salari, Shiva Maleki, Nahad Sedaghat
medRxiv 2021.10.17.21265114; doi: https://doi.org/10.1101/2021.10.17.21265114
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12781)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4609)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (391)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4388)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6980)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)